🇺🇸 FDA

Drug profile · INN

sodium zirconium cyclosilicate

LOKELMA

FDA: approved EMA: approved V03AE10
US status
approved
Patents linked
0
News articles
0

Quick answer

sodium zirconium cyclosilicate (LOKELMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN sodium zirconium cyclosilicate
Brand LOKELMA
Route ORAL
Formulation POWDER, FOR SUSPENSION
ATC code V03AE10

Frequently asked questions

What is sodium zirconium cyclosilicate?

sodium zirconium cyclosilicate (LOKELMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for sodium zirconium cyclosilicate?

LOKELMA is a marketed brand name for sodium zirconium cyclosilicate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium zirconium cyclosilicate?

sodium zirconium cyclosilicate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.